The Anticancer Effects of MPT0G211, a Novel HDAC6 Inhibitor, Combined With Chemotherapeutic Agents in Human Acute Leukemia Cells

Clinical Epigenetics - Germany
doi 10.1186/s13148-018-0595-8

Related search